Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test

European Journal of Anaesthesiology

Volumn 23, Issue 1, 2006, Pages 65-70

  Yoon, M H ^a   Choi, J I ^a   Kim, S J ^a   Kim, C M ^a   Bae, H B ^a   Chung, S T ^a  

^a Chonnam National University   (South Korea)

Author keywords

Analgesia; Drug interactions; Injection, intrathecal; Neurotransmitter, opioid, phosphodiesterase; Pain measurement, formalin test; Rats, Sprague Dawley

Indexed keywords

MORPHINE; ZAPRINAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NEUROTRANSMISSION; NONHUMAN; PAIN; RAT;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FORMALDEHYDE; INJECTIONS, SPINAL; MALE; MORPHINE; MUSCLE TONUS; PAIN; PAIN MEASUREMENT; PHOSPHODIESTERASE INHIBITORS; PURINONES; RATS; RATS, SPRAGUE-DAWLEY; REFLEX;

EID: 29844434744     PISSN: 02650215     EISSN: 02650215     Source Type: Journal    
DOI: 10.1017/S0265021505001791     Document Type: Article

References (28)

1. Ferreira SH, Nakamura M. Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 1979; 18: 179-190.
2. Sousa AM, Prado WA. The dual effect of a nitric oxide donor in nociception. Brain Res 2001; 897: 9-19.
3. Pyne NJ, Arshavsky V, Lochhead A. cGMP signal termination. Biochem Soc Trans 1996; 24: 1019-1022.
4. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-748.
5. Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soto V. Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol 2000; 400: 81-87.
6. Jain NK, Patil CS, Singh A, Kulkarni SK. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001; 909: 170-178.
7. Asomoza-Espinosa R, Alonso-Lopez R, Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Torres-Lopez JE, Granados-Soto V. Sildenafil increases diclofenac antinociception in the formalin test. Eur J Pharmacol 2001; 418: 195-200.
8. Jain NK, Patil CS, Singh A, Kulkarni SK. Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine. Pharmacology 2003; 67: 150-156.
9. Patil CS, Jain NK, Singh A, Kulkarni SK. Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception. Pharmacology 2003; 69: 183-189.
10. Cunha FQ, Teixeira MM, Ferreira SH. Pharmacological modulation of secondary mediator systems - cyclic AMP and cyclic GMP - on inflammatory hyperalgesia. Br J Pharmacol 1999; 127: 671-678.
11. Amarante LH, Duarte ID. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway. Eur J Pharmacol 2002; 454: 19-23.
12. Jeong CY, Choi JI, Yoon MH. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 2004; 502: 205-211.
13. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-1036.
14. Coderre TJ, Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur J Neurosci 1994; 6: 1328-1334.
15. Okuda K, Sakurada C, Takahashi M, Yamada T, Sakurada T Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats. Pain 2001; 92: 107-115.
16. Malmber AB, Yaksh TL. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther 1992; 263: 264-275.
17. Yoon MH, Choi JI. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test. Anesthesiology 2003; 99: 701-707.
18. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 1989; 45: 9947-9961.
19. Roerig SC, Fujimoto JM. Morphine antinociception in different strains of mice: relationship of supraspinal-spinal multiplicative interaction to tolerance. J Pharmacol Exp Ther 1988; 247: 603-608.
20. Nishiyama T. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. Eur J Pharmacol 2000; 395: 203-210.
21. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculations with Computer Programs, 2nd edn. New York, USA: Springer-Verlag, 1987.
22. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11: 150-155.
23. Moreland RB, Goldstein II, Kim NN, Traish A. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endocrinol Metab 1999; 10: 97-104.
24. Przesmycki K, Dzieciuch JA, Czuczwar SJ, Kleinrok Z. Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. Eur J Pharmacol 1997; 337: 11-17.
25. Duale C, Raboisson P, Molat JL, Dallel R. Systemic morphine reduces the wind-up of trigeminal nociceptive neurons. Neuroreport 2001; 12: 2091-2096.
26. Ferreira SH, Duarte IDG, Lorenzetti BB. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991; 201: 121-122.
27. Granados-Soto V, Rufino MO, Gomes Lopes LD, Ferreira SH. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol 1997; 340: 177-180.
28. Minneman KP, Iversen IL. Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Nature 1976; 262: 313-314.